Isn't that figure specific for secondary composite endpoints?
Yes.
And our secondary composite endpoint is 3 point MACE (Hard MACE).
Figure 3 (facing page). Key Secondary Efficacy Composite End Point in Selected Prespecified Subgroups.
Shown are the hazard ratios and 95% confidence intervals for the key secondary efficacy composite end point of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke, as assessed in a time-to event analysis, in selected prespecified subgroups of the intention-to-treat population.